The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global VLP Vaccines Market Research Report 2024
Synopsis
VLP vaccines are a type of recombinant vaccine, but they offer the efficiency of a live-attenuated vaccine. Recombinant vaccines use a particular piece of the germ that the immune system targets specifically.
The global VLP Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for VLP Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VLP Vaccines.
Report Scope
The VLP Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global VLP Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the VLP Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medicago
Novavax
Saiba Animal Health
VBI
ARTES Biotechnology
VLP Therapeutics
POSVAX
Spybiotech
Optipharm Co. Ltd
H&Z Life Science
Gproan
Merck
Segment by Type
HPV Vaccine
Covid-19 Vaccine
Hepatitis B Vaccine
Others
Segment by Application
Government
Medical Institution
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of VLP Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of VLP Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
VLP vaccines are a type of recombinant vaccine, but they offer the efficiency of a live-attenuated vaccine. Recombinant vaccines use a particular piece of the germ that the immune system targets specifically.
The global VLP Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for VLP Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VLP Vaccines.
Report Scope
The VLP Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global VLP Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the VLP Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medicago
Novavax
Saiba Animal Health
VBI
ARTES Biotechnology
VLP Therapeutics
POSVAX
Spybiotech
Optipharm Co. Ltd
H&Z Life Science
Gproan
Merck
Segment by Type
HPV Vaccine
Covid-19 Vaccine
Hepatitis B Vaccine
Others
Segment by Application
Government
Medical Institution
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of VLP Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of VLP Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 VLP Vaccines Market Overview
1.1 Product Overview and Scope of VLP Vaccines
1.2 VLP Vaccines Segment by Type
1.2.1 Global VLP Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 HPV Vaccine
1.2.3 Covid-19 Vaccine
1.2.4 Hepatitis B Vaccine
1.2.5 Others
1.3 VLP Vaccines Segment by Application
1.3.1 Global VLP Vaccines Market Value by Application: (2024-2030)
1.3.2 Government
1.3.3 Medical Institution
1.3.4 Others
1.4 Global VLP Vaccines Market Size Estimates and Forecasts
1.4.1 Global VLP Vaccines Revenue 2019-2030
1.4.2 Global VLP Vaccines Sales 2019-2030
1.4.3 Global VLP Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 VLP Vaccines Market Competition by Manufacturers
2.1 Global VLP Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global VLP Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global VLP Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global VLP Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of VLP Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of VLP Vaccines, Product Type & Application
2.7 VLP Vaccines Market Competitive Situation and Trends
2.7.1 VLP Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest VLP Vaccines Players Market Share by Revenue
2.7.3 Global VLP Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 VLP Vaccines Retrospective Market Scenario by Region
3.1 Global VLP Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global VLP Vaccines Global VLP Vaccines Sales by Region: 2019-2030
3.2.1 Global VLP Vaccines Sales by Region: 2019-2024
3.2.2 Global VLP Vaccines Sales by Region: 2025-2030
3.3 Global VLP Vaccines Global VLP Vaccines Revenue by Region: 2019-2030
3.3.1 Global VLP Vaccines Revenue by Region: 2019-2024
3.3.2 Global VLP Vaccines Revenue by Region: 2025-2030
3.4 North America VLP Vaccines Market Facts & Figures by Country
3.4.1 North America VLP Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America VLP Vaccines Sales by Country (2019-2030)
3.4.3 North America VLP Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe VLP Vaccines Market Facts & Figures by Country
3.5.1 Europe VLP Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe VLP Vaccines Sales by Country (2019-2030)
3.5.3 Europe VLP Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific VLP Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific VLP Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific VLP Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific VLP Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America VLP Vaccines Market Facts & Figures by Country
3.7.1 Latin America VLP Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America VLP Vaccines Sales by Country (2019-2030)
3.7.3 Latin America VLP Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa VLP Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa VLP Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa VLP Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa VLP Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global VLP Vaccines Sales by Type (2019-2030)
4.1.1 Global VLP Vaccines Sales by Type (2019-2024)
4.1.2 Global VLP Vaccines Sales by Type (2025-2030)
4.1.3 Global VLP Vaccines Sales Market Share by Type (2019-2030)
4.2 Global VLP Vaccines Revenue by Type (2019-2030)
4.2.1 Global VLP Vaccines Revenue by Type (2019-2024)
4.2.2 Global VLP Vaccines Revenue by Type (2025-2030)
4.2.3 Global VLP Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global VLP Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global VLP Vaccines Sales by Application (2019-2030)
5.1.1 Global VLP Vaccines Sales by Application (2019-2024)
5.1.2 Global VLP Vaccines Sales by Application (2025-2030)
5.1.3 Global VLP Vaccines Sales Market Share by Application (2019-2030)
5.2 Global VLP Vaccines Revenue by Application (2019-2030)
5.2.1 Global VLP Vaccines Revenue by Application (2019-2024)
5.2.2 Global VLP Vaccines Revenue by Application (2025-2030)
5.2.3 Global VLP Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global VLP Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medicago
6.1.1 Medicago Corporation Information
6.1.2 Medicago Description and Business Overview
6.1.3 Medicago VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medicago VLP Vaccines Product Portfolio
6.1.5 Medicago Recent Developments/Updates
6.2 Novavax
6.2.1 Novavax Corporation Information
6.2.2 Novavax Description and Business Overview
6.2.3 Novavax VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novavax VLP Vaccines Product Portfolio
6.2.5 Novavax Recent Developments/Updates
6.3 Saiba Animal Health
6.3.1 Saiba Animal Health Corporation Information
6.3.2 Saiba Animal Health Description and Business Overview
6.3.3 Saiba Animal Health VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Saiba Animal Health VLP Vaccines Product Portfolio
6.3.5 Saiba Animal Health Recent Developments/Updates
6.4 VBI
6.4.1 VBI Corporation Information
6.4.2 VBI Description and Business Overview
6.4.3 VBI VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VBI VLP Vaccines Product Portfolio
6.4.5 VBI Recent Developments/Updates
6.5 ARTES Biotechnology
6.5.1 ARTES Biotechnology Corporation Information
6.5.2 ARTES Biotechnology Description and Business Overview
6.5.3 ARTES Biotechnology VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ARTES Biotechnology VLP Vaccines Product Portfolio
6.5.5 ARTES Biotechnology Recent Developments/Updates
6.6 VLP Therapeutics
6.6.1 VLP Therapeutics Corporation Information
6.6.2 VLP Therapeutics Description and Business Overview
6.6.3 VLP Therapeutics VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 VLP Therapeutics VLP Vaccines Product Portfolio
6.6.5 VLP Therapeutics Recent Developments/Updates
6.7 POSVAX
6.6.1 POSVAX Corporation Information
6.6.2 POSVAX Description and Business Overview
6.6.3 POSVAX VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 POSVAX VLP Vaccines Product Portfolio
6.7.5 POSVAX Recent Developments/Updates
6.8 Spybiotech
6.8.1 Spybiotech Corporation Information
6.8.2 Spybiotech Description and Business Overview
6.8.3 Spybiotech VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Spybiotech VLP Vaccines Product Portfolio
6.8.5 Spybiotech Recent Developments/Updates
6.9 Optipharm Co. Ltd
6.9.1 Optipharm Co. Ltd Corporation Information
6.9.2 Optipharm Co. Ltd Description and Business Overview
6.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Optipharm Co. Ltd VLP Vaccines Product Portfolio
6.9.5 Optipharm Co. Ltd Recent Developments/Updates
6.10 H&Z Life Science
6.10.1 H&Z Life Science Corporation Information
6.10.2 H&Z Life Science Description and Business Overview
6.10.3 H&Z Life Science VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 H&Z Life Science VLP Vaccines Product Portfolio
6.10.5 H&Z Life Science Recent Developments/Updates
6.11 Gproan
6.11.1 Gproan Corporation Information
6.11.2 Gproan VLP Vaccines Description and Business Overview
6.11.3 Gproan VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Gproan VLP Vaccines Product Portfolio
6.11.5 Gproan Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck VLP Vaccines Description and Business Overview
6.12.3 Merck VLP Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Merck VLP Vaccines Product Portfolio
6.12.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 VLP Vaccines Industry Chain Analysis
7.2 VLP Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 VLP Vaccines Production Mode & Process
7.4 VLP Vaccines Sales and Marketing
7.4.1 VLP Vaccines Sales Channels
7.4.2 VLP Vaccines Distributors
7.5 VLP Vaccines Customers
8 VLP Vaccines Market Dynamics
8.1 VLP Vaccines Industry Trends
8.2 VLP Vaccines Market Drivers
8.3 VLP Vaccines Market Challenges
8.4 VLP Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global VLP Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global VLP Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global VLP Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global VLP Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global VLP Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global VLP Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global VLP Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market VLP Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of VLP Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of VLP Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of VLP Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of VLP Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VLP Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VLP Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VLP Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global VLP Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global VLP Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global VLP Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global VLP Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global VLP Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global VLP Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global VLP Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global VLP Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific VLP Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific VLP Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific VLP Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific VLP Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific VLP Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global VLP Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global VLP Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global VLP Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global VLP Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global VLP Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global VLP Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global VLP Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global VLP Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global VLP Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global VLP Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global VLP Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global VLP Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global VLP Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global VLP Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global VLP Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global VLP Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global VLP Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global VLP Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global VLP Vaccines Price (US$/Dose) by Application (2019-2024)
Table 69. Global VLP Vaccines Price (US$/Dose) by Application (2025-2030)
Table 70. Medicago Corporation Information
Table 71. Medicago Description and Business Overview
Table 72. Medicago VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Medicago VLP Vaccines Product
Table 74. Medicago Recent Developments/Updates
Table 75. Novavax Corporation Information
Table 76. Novavax Description and Business Overview
Table 77. Novavax VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Novavax VLP Vaccines Product
Table 79. Novavax Recent Developments/Updates
Table 80. Saiba Animal Health Corporation Information
Table 81. Saiba Animal Health Description and Business Overview
Table 82. Saiba Animal Health VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Saiba Animal Health VLP Vaccines Product
Table 84. Saiba Animal Health Recent Developments/Updates
Table 85. VBI Corporation Information
Table 86. VBI Description and Business Overview
Table 87. VBI VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. VBI VLP Vaccines Product
Table 89. VBI Recent Developments/Updates
Table 90. ARTES Biotechnology Corporation Information
Table 91. ARTES Biotechnology Description and Business Overview
Table 92. ARTES Biotechnology VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. ARTES Biotechnology VLP Vaccines Product
Table 94. ARTES Biotechnology Recent Developments/Updates
Table 95. VLP Therapeutics Corporation Information
Table 96. VLP Therapeutics Description and Business Overview
Table 97. VLP Therapeutics VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. VLP Therapeutics VLP Vaccines Product
Table 99. VLP Therapeutics Recent Developments/Updates
Table 100. POSVAX Corporation Information
Table 101. POSVAX Description and Business Overview
Table 102. POSVAX VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. POSVAX VLP Vaccines Product
Table 104. POSVAX Recent Developments/Updates
Table 105. Spybiotech Corporation Information
Table 106. Spybiotech Description and Business Overview
Table 107. Spybiotech VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Spybiotech VLP Vaccines Product
Table 109. Spybiotech Recent Developments/Updates
Table 110. Optipharm Co. Ltd Corporation Information
Table 111. Optipharm Co. Ltd Description and Business Overview
Table 112. Optipharm Co. Ltd VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Optipharm Co. Ltd VLP Vaccines Product
Table 114. Optipharm Co. Ltd Recent Developments/Updates
Table 115. H&Z Life Science Corporation Information
Table 116. H&Z Life Science Description and Business Overview
Table 117. H&Z Life Science VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. H&Z Life Science VLP Vaccines Product
Table 119. H&Z Life Science Recent Developments/Updates
Table 120. Gproan Corporation Information
Table 121. Gproan Description and Business Overview
Table 122. Gproan VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Gproan VLP Vaccines Product
Table 124. Gproan Recent Developments/Updates
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Merck VLP Vaccines Product
Table 129. Merck Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. VLP Vaccines Distributors List
Table 133. VLP Vaccines Customers List
Table 134. VLP Vaccines Market Trends
Table 135. VLP Vaccines Market Drivers
Table 136. VLP Vaccines Market Challenges
Table 137. VLP Vaccines Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of VLP Vaccines
Figure 2. Global VLP Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global VLP Vaccines Market Share by Type in 2023 & 2030
Figure 4. HPV Vaccine Product Picture
Figure 5. Covid-19 Vaccine Product Picture
Figure 6. Hepatitis B Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global VLP Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global VLP Vaccines Market Share by Application in 2023 & 2030
Figure 10. Government
Figure 11. Medical Institution
Figure 12. Others
Figure 13. Global VLP Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global VLP Vaccines Market Size (2019-2030) & (US$ Million)
Figure 15. Global VLP Vaccines Sales (2019-2030) & (K Doses)
Figure 16. Global VLP Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 17. VLP Vaccines Report Years Considered
Figure 18. VLP Vaccines Sales Share by Manufacturers in 2023
Figure 19. Global VLP Vaccines Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest VLP Vaccines Players: Market Share by Revenue in 2023
Figure 21. VLP Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global VLP Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 24. North America VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 25. United States VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific VLP Vaccines Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific VLP Vaccines Revenue Market Share by Region (2019-2030)
Figure 36. China VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of VLP Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of VLP Vaccines by Type (2019-2030)
Figure 57. Global VLP Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of VLP Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of VLP Vaccines by Application (2019-2030)
Figure 60. Global VLP Vaccines Price (US$/Dose) by Application (2019-2030)
Figure 61. VLP Vaccines Value Chain
Figure 62. VLP Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
